NLS Pharma Group this week announced that it has begun enrollment for its Phase II clinical trial for Mazindol, which will be conducted on adults with DSM-5 Attention Deficit Hyperactivity Disorder (ADHD). Read More »
Pfizer Inc. has announced that it has reached an agreement with AstraZeneca for the acquisition of the development and commercialization rights to its late-stage small molecule anti-infectives business. Read More »
Therapy combines Vigil engineered autologous tumor cells with durvalumab. Read More »
Mallinckrodt plc, a specialty pharmaceutical company and a worldwide leader, has announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) application for Synacthen Depot Fast Track designation. Read More »
TG Therapeutics Inc. recently announced that it has received orphan drug designation for TG-1101, otherwise known as ublituximab, from the U.S. Food and Drug Administration (FDA). Read More »
Genmab recently announced that its data from the Phase III CASTOR study of daratumumab, which was presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting and at the 21st Congress of the European Hematology Association (EHA), has been published by the New England Journal of Medicine. Read More »
Crown Bioscience recently announced that Amar Thyagarajan, Ph.D., and Sandeep Sinha, Ph.D., will be joining its leadership team. Read More »
PinnacleHealth recently became the first hospital in the United States to implant the EDWARDS INTUITY Elite valve, which is a fast-deployment device for the replacement of a surgical aortic valve. Read More »
Amid the furor caused by the publicity surrounding Mylan's more than 400 percent price increase on the life-saving EpiPen, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt challenged the price-hike justification. Read More »
Will present 11 abstracts at the conference in Rome on Aug. 27-31. Read More »
Miltefosine was used to treat Naegleria fowleri infection; the teen is only the third survivor of primary amebic meningoencephalitis. Read More »
Human iPSC-derived beta cells now available for drug screening and diabetes research. Read More »
Over the past decade, CVS Health has invested more than $1.5 million to Easterseals in early childhood services, which has ensured the best possible start in life for tens of thousands of young children. Read More »
Joins experienced management team; will oversee contract sales organization. Read More »
Raptor Pharmaceuticals Corp., a biopharmaceutical company focused on the development and commercialization of transformative treatments to treat rare diseases, has announced its participation in the European Respiratory Society (ERS) International Congress 2016. Read More »
Aclaris announces results of A-101 topical solution to treat the common wart. Read More »
Health Center Partners, a group of community health centers in San Diego, Riverside and Imperial counties in California, recently announced that is has been named the recipient of $1.5 million from the U.S. Department of Health and Human Services (HHS). Read More »
Stanley Crooke, founder, CEO and chairman of Ionis Pharmaceuticals, has been named the recipient of the E. B. Hershberg Award by the American Chemical Society for significant discoveries in medicinally active substances. Read More »
Men who received placebo and subsequent treatment with fexapotide show lower surgery rates. Read More »
A majority of health care plans and programs with a drug exclusion policy have been successful, reducing costs and not negatively impacting patient care, concludes a new study published in The American Journal of Managed Care. Read More »
Alerts Sign-up
